Ckd Bio Cash Flow Conversion Efficiency

Latest as of June 2026: 0.022x

Ckd Bio cash flow conversion efficiency. Based on the latest financial reports, Ckd Bio (063160) has a cash flow conversion efficiency ratio of 0.022x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.62 Billion ≈ $1.77 Million USD) by net assets (₩119.57 Billion ≈ $81.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Ckd Bio (2008–2025)

Cash flow conversion efficiency of Ckd Bio from 2008 to 2025. This chart illustrates how Ckd Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Ckd Bio (063160) stock price for real-time trading data and today's change.

Ckd Bio Cash Flow Conversion Ratio Explained

Ckd Bio cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Ckd Bio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ckd Bio ranked by their cash flow conversion efficiency. Also see Ckd Bio (063160) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mindax Ltd AU:MDX	-0.040x
Jerash Holdings US Inc NASDAQ:JRSH	-0.060x
Terracom Ltd AU:TER	-0.082x
MeVis Medical Solutions AG XETRA:M3V	0.005x
Frigoglass S.A.I.C. AT:FRIGO	-0.626x
Xander International TWO:6118	-0.158x
Corentec Co Ltd KQ:104540	0.100x
MODULIGHT OY EO 1 F:78W	0.001x

Annual Cash Flow Conversion Efficiency for Ckd Bio (2008–2025)

The table below shows the annual cash flow conversion efficiency of Ckd Bio from 2008 to 2025. Review how much free cash does Ckd Bio generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩127.04 Billion ≈ $86.09 Million	₩-4.14 Billion ≈ $-2.81 Million	-0.033x	-130.45%
2024-12-31	₩131.01 Billion ≈ $88.78 Million	₩14.03 Billion ≈ $9.51 Million	0.107x	+282.39%
2023-12-31	₩123.02 Billion ≈ $83.37 Million	₩-7.22 Billion ≈ $-4.90 Million	-0.059x	-170.82%
2022-12-31	₩147.80 Billion ≈ $100.16 Million	₩-3.20 Billion ≈ $-2.17 Million	-0.022x	+40.47%
2021-12-31	₩161.49 Billion ≈ $109.44 Million	₩-5.88 Billion ≈ $-3.99 Million	-0.036x	-227.41%
2020-12-31	₩168.75 Billion ≈ $114.36 Million	₩4.82 Billion ≈ $3.27 Million	0.029x	-73.34%
2019-12-31	₩158.46 Billion ≈ $107.39 Million	₩16.99 Billion ≈ $11.51 Million	0.107x	+1.91%
2018-12-31	₩147.66 Billion ≈ $100.07 Million	₩15.54 Billion ≈ $10.53 Million	0.105x	-26.90%
2017-12-31	₩142.05 Billion ≈ $96.26 Million	₩20.45 Billion ≈ $13.86 Million	0.144x	+25.52%
2016-12-31	₩135.16 Billion ≈ $91.60 Million	₩15.50 Billion ≈ $10.50 Million	0.115x	+1.87%
2015-12-31	₩127.38 Billion ≈ $86.32 Million	₩14.34 Billion ≈ $9.72 Million	0.113x	+22.22%
2014-12-31	₩121.85 Billion ≈ $82.57 Million	₩11.22 Billion ≈ $7.61 Million	0.092x	+4.45%
2013-12-31	₩123.87 Billion ≈ $83.95 Million	₩10.92 Billion ≈ $7.40 Million	0.088x	-52.19%
2012-12-31	₩124.15 Billion ≈ $84.13 Million	₩22.90 Billion ≈ $15.52 Million	0.184x	+69.33%
2011-12-31	₩119.00 Billion ≈ $80.65 Million	₩12.96 Billion ≈ $8.79 Million	0.109x	-65.28%
2010-12-31	₩76.14 Billion ≈ $51.60 Million	₩23.89 Billion ≈ $16.19 Million	0.314x	-24.35%
2009-12-31	₩64.08 Billion ≈ $43.42 Million	₩26.57 Billion ≈ $18.01 Million	0.415x	+90.70%
2008-12-31	₩49.15 Billion ≈ $33.31 Million	₩10.69 Billion ≈ $7.24 Million	0.217x	--

About Ckd Bio

KO:063160 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.53 Million

₩62.76 Billion KRW

Market Cap Rank

#22298 Global

#1410 in Korea

Share Price

₩11440.00

Change (1 day)

-4.59%

52-Week Range

₩11440.00 - ₩22750.00

All Time High

₩101057.67